HBV-IN-41
Product Specifications
UNSPSC Description
HBV-IN-41 (compound 45) is a potent and orally active Hepatitis B Virus (HBV) inhibitor, with an EC50 of 0.027μM[1].
Target Antigen
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-in-41.html
Solubility
10 mM in DMSO
Smiles
C[C@H]1CN2C(CN1C(NC3=CC(Cl)=C(C=C3)F)=O)=C(C=N2)N4CCOCC4=O
Molecular Weight
407.83
References & Citations
[1]Kou B, et al. Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. J Med Chem. 2023 Oct 6.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156272/HBV-IN-41-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156272/
Clinical Information
No Development Reported
CAS Number
1967002-25-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7111923 Inquire
Recombinant Mouse G protein-activated inward rectifier potassium channel 2 (Kcnj6), partial
Ask
View Details 
